`
`
`
`
`
`
`Exhibit B
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 2 of 13 PageID #: 15780
`
`
`IN THE UNITED STATES DISTRICT
`COURT FOR THE EASTERN DISTRICT
`OF TEXAS MARSHALL DIVISION
`
`
`
`ALLERGAN, INC.,
`
`
`v.
`
`
`
`
`
`
`Plaintiff,
`
`
`
`
`
`
` Defendants.
`
`Civil Action No. 2:15-cv-1455-WCB
`
`LEAD CASE
`
`
`
`
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`ET AL.,
`
`
`DEFENDANTS’ INITIAL TRIAL WITNESS LIST FOR ISSUES
`WHERE DEFENDANTS HAVE THE BURDEN OF PROOF
`
`Defendants, pursuant to the Court’s Twelfth Amended Docket Control Order entered in
`
`this case, file this Initial Trial Witness List for identification and categorization of trial witnesses.
`
`
`
`At this time, Defendants hereby disclose the following list of witnesses that they will or
`
`may call at trial to testify in person or by deposition designation. Defendants reserve the right to
`
`revise or supplement this list consistent with the Pretrial Order or as otherwise permitted by the
`
`Court. Furthermore, Defendants reserve the right to call additional witnesses live or by
`
`deposition designations (or to offer additional deposition designations from witnesses identified
`
`herein) in rebuttal to issues raised in Plaintiff’s case-in-chief or rebuttal presentations.
`
`Defendants further reserve the right to call additional witnesses live or by deposition designation
`
`to respond to issues raised after the preparation and submission of this list, including any changes
`
`by Plaintiff to its arguments, witness lists, or other positions. Defendants further reserve the
`
`right to call any witness live or by deposition designations for purposes of impeachment.
`
`Defendants further reserve the right to call additional witnesses live or by deposition
`
`designations (or to offer additional deposition designations from witnesses identified herein) to
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 3 of 13 PageID #: 15781
`
`
`the extent necessary to provide foundational testimony if Plaintiff contests the authenticity or
`
`admissibility of any materials to be offered as evidence at trial. Defendants further reserve the
`
`right to substitute witnesses for the listed witnesses should any listed witness become unavailable
`
`for trial. Defendants further reserve the right to use any deposition designations identified by
`
`Defendants as either affirmative designations or as counter-designations. For all expert witnesses
`
`listed by Plaintiff, Defendants reserve the right to introduce deposition testimony in the event
`
`that such witness does not testify live at trial. Defendants further reserve the right to call any
`
`witness listed by Plaintiff on its witness list or initial disclosures (as noted below), or who
`
`otherwise appears for Plaintiff at trial.
`
`
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`WITNESS
`Justin Hanes
`
`Andrew Calman
`
`Daniel Bloch
`
`Ivan Hofmann
`
`Thorsteinn Loftsson
`
`Henry Perry
`
`Timothy MacDonald
`
`Stephen Pflugfelder
`
`Robert Maness
`
`(A)
`WILL CALL
`LIVE1
`X
`
`(B)
`MAY CALL
`LIVE
`
`
`(C)
`MAY CALL
`BY
`DEPOSITION
`
`
`X
`
`X
`
`X
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`X
`
`X
`
`X
`
`X
`
`X
`
`
`1 To the extent that a witness is not available to offer live testimony, Defendants may present
`deposition testimony for each such witness, irrespective of whether the witness is designated as
`may call by deposition.
`
`
`
`2
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 4 of 13 PageID #: 15782
`
`
`(A)
`WILL CALL
`LIVE1
`
`
`(B)
`MAY CALL
`LIVE
`
`
`(C)
`MAY CALL
`BY
`DEPOSITION
`X
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`
`
`
`
`WITNESS
`Andrew Acheampong
`
`Mayssa Attar
`
`Peter Bakhit
`
`James Chang
`
`Shulin Ding
`
`David LeCause
`
`Thomas Mundorf
`
`Orest Olejnik
`
`David Power
`
`Brenda Reis
`
`Kenneth Sall
`
`Rhett Schiffman
`
`Diane Tang-Liu
`
`Any witness included on
`Allergan’s witness list or
`in its initial disclosures2
`
`
`
`
`2 Defendants have designated any Allergan witnesses as “may call live” and “may call by
`deposition” in the event that Allergan does not call any of its witnesses live at trial or attempts to
`limit the scope of cross-examination to subject matter elicited during direct examination.
`
`
`
`3
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 5 of 13 PageID #: 15783
`
`
`
`
`
`
`Dated: June 13, 2017
`
`
` /s/ Anna G. Phillips
`Douglas H. Carsten
`Wendy Devine
`Christina E. Dashe
`Alina L. Litoshyk
`Nellie J. Amjadi
`WILSON SONSINI GOODRICH & ROSATI
`12235 El Camino Real, Suite 200
`San Diego, CA 92130-3002
`Tel: 858-350-2300
`Fax: 858-350-2399
`dcarsten@wsgr.com
`wdevine@wsgr.com
`cdashe@wsgr.com
`alitoshyk@wsgr.com
`namjadi@wsgr.com
`
`Anna G. Phillips
`Texas Bar No. 24090329
`WILSON SONSINI GOODRICH & ROSATI
`900 South Capital of Texas Highway
`Las Cimas IV, Fifth Floor
`Austin, TX 78746-5546
`Tel: 512-338-5400
`Fax: 512-338-5499
`anphillips@wsgr.com
`
`Melissa Smith
`Allen Franklin Gardner
`GILLAM & SMITH LLP
`303 S. Washington Ave.
`Marshall, Texas 75670
`Tel: 903-934-8450
`Fax: 903-934-9257
`melissa@gillamsmithlaw.com
`allen@gillamsmithlaw.com
`
`COUNSEL FOR DEFENDANTS MYLAN
`PHARMACEUTICALS INC. AND
`MYLAN INC.
`
`
`
`
`
`
`
`Respectfully submitted,
`
` /s/ J.C. Rozendaal
`J.C. Rozendaal (pro hac vice)
`Michael E. Joffre (pro hac vice)
`Pauline M. Pelletier (pro hac vice)
`R. Wilson Powers III (pro hac vice)
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Ave. NW, Suite 600
`Washington, DC 20005
`Tel: 202-371-2600
`Fax: 202-371-2540
`jcrozendaal@skgf.com
`mjoffre@skgf.com
`ppelletier@skgf.com
`tpowers@skgf.com
`
`Louis B. (“Brady”) Paddock
`Texas Bar No. 00791394
`NIX, PATTERSON & ROACH L.L.P.
`2900 St. Michael Drive, Ste. 500
`Texarkana, TX 75503
`(903) 223-3999
`(903) 223-8520 (fax)
`bpaddock@nixlawfirm.com
`
`COUNSEL FOR DEFENDANT
`TEVA PHARMACEUTICALS USA, INC.
`
` /s/ Jason Craig Hamilton
`Stephen R. Smerek (pro hac vice)
`Shilpa Coorg (pro hac vice)
`Jason Craig Hamilton (pro hac vice)
`WINSTON & STRAWN LLP
`333 South Grand Avenue, 38th Floor
`Los Angeles, CA 90071-1543
`Tel: 213-615-1933
`Fax: 213-615-1750
`ssmerek@winston.com
`scoorg@winston.com
`jhamilton@winston.com
`
`Charles B. Klein (pro hac vice)
`WINSTON & STRAWN LLP
`
`
`
`
`
`4
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 6 of 13 PageID #: 15784
`
`
`
`
` /s/ Azadeh Kokabi
`Michael R. Dzwonczyk
`Azadeh Kokabi
`Mark Boland
`SUGHRUE MION PLLC
`2100 Pennsylvania Ave NW, Suite 800
`Washington, DC 20037
`Tel: 202-293-7060
`Fax: 202-293-7860
`mdzwonczyk@sughrue.com
`akokabi@sughrue.com
`mboland@sughrue.com
`
`Earl Glenn Thames, Jr.
`POTTER MINTON
`110 N College Avenue, Suite 500
`Tyler, TX 75702
`Tel: 903-597-8311
`Fax: 903-593-0846
`glennthames@potterminton.com
`
`COUNSEL FOR DEFENDANT
`AKORN, INC.
`
`
`
`
`
`
`
`
`
`
`
`
`
`1700 K Street, NW
`Washington, DC 20006
`Tel: 202-282-5977
`Fax: 202-282-5100
`cklein@winston.com
`Deron R. Dacus
`Peter Aaron Kerr
`THE DACUS FIRM, PC
`821 ESE Loop 323, Suite 430
`Tyler, TX 75701
`Tel: 903-705-1117
`Fax: 903-581-2543
`ddacus@dacusfirm.com
`pkerr@dacusfirm.com
`
`COUNSEL FOR DEFENDANT
`INNOPHARMA, INC.
`
` /s/ Peter J. Curtin
`William A. Rakoczy (pro hac vice)
`Paul J. Molino (pro hac vice)
`Peter J. Curtin (pro hac vice)
`John D. Polivick (pro hac vice)
`Kevin P. Burke (pro hac vice)
`Patrick N. Abbott (pro hac vice)
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-6301
`Fax: (312) 222-6321
`wrakoczy@rmmslegal.com
`paul@rmmslegal.com
`jpolivick@rmmslegal.com
`kburke@rmmslegal.com
`pabbott@rmmslegal.com
`
`Eric H. Findlay
`Texas Bar No. 00789886
`Walter Wayne Lackey, Jr.
`Texas Bar No. 24050901
`FINDLAY CRAFT, P.C.
`102 North College Avenue, Suite900
`Tyler, TX 75702
`Tel: (903) 534-1100
`Fax: (903) 534-1137
`
`COUNSEL FOR DEFENDANT
`FAMY CARE LIMITED
`
`5
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 7 of 13 PageID #: 15785
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that a true and correct copy of the above and foregoing was served upon
`
`all counsel of record via e-mail on June 13, 2017.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ J.C. Rozendaal
`J.C. Rozendaal
`
`
`
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 8 of 13 PageID #: 15786
`
`
`
`IN THE UNITED STATES DISTRICT
`COURT FOR THE EASTERN DISTRICT
`OF TEXAS MARSHALL DIVISION
`
`
`
`ALLERGAN, INC.,
`
`
`v.
`
`
`
`
`
`
`Plaintiff,
`
`
`
`
`
`
` Defendants.
`
`Civil Action No. 2:15-cv-1455-WCB
`
`LEAD CASE
`
`
`
`
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`ET AL.,
`
`
`DEFENDANTS’ REBUTTAL TRIAL WITNESS LIST
`
`Defendants, pursuant to the Court’s Thirteenth Amended Docket Control Order entered
`
`in this case, file this Rebuttal Trial Witness List for identification and categorization of trial
`
`witnesses. At this time, Defendants hereby disclose the following list of witnesses that they will
`
`or may call at trial to testify in person or by deposition designation.
`
`
`
`WITNESS
`1. Andrew Calman
`
`2. Nicholas Fleischer
`
`3. David Mitchell
`
`4. Manoj Pananchukunnath
`
`5.
`
`Joseph Sobecki
`
`6. Subrahmanyam Boddapati
`
`(A)
`WILL CALL
`LIVE1
`X
`
`(B)
`MAY CALL
`LIVE
`
`
`(C)
`MAY CALL
`BY
`DEPOSITION
`
`
`X
`
`
`
`
`
`
`
`
`
`
`
`X
`
`X
`
`X
`
`X
`
`
`
`X
`
`X
`
`X
`
`X
`
`
`1 To the extent that a witness is not available to offer live testimony, Defendants may present
`deposition testimony for each such witness, irrespective of whether the witness is designated as
`may call by deposition.
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 9 of 13 PageID #: 15787
`
`
`
`
`WITNESS
`Jennifer Bowles
`
`7.
`
`8. Sean Brynjelsen
`
`9. Deborah DuFresne
`
`10. David Edwards
`
`11. Kevin Hawkins
`
`12. Caroline Hill
`
`13. Sasank Kunadharaju
`
`14. Satish Pejaver
`
`15. Cory Wohlbach
`
`16. Any witness included on
`Allergan’s witness list or
`in its initial disclosures2
`
`
`
`(A)
`WILL CALL
`LIVE1
`
`
`(B)
`MAY CALL
`LIVE
`X
`
`(C)
`MAY CALL
`BY
`DEPOSITION
`X
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`X
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`Defendants reserve the right to revise or supplement this list consistent with the Pretrial
`
`Order or as otherwise permitted by the Court. Furthermore, Defendants reserve the right to call
`
`additional witnesses live or by deposition designations (or to offer additional deposition
`
`designations from witnesses identified herein) in rebuttal to issues raised in Plaintiff’s case-in-
`
`chief or rebuttal presentations. Defendants further reserve the right to call additional witnesses
`
`live or by deposition designation to respond to issues raised after the preparation and submission
`
`2 Defendants have designated any Allergan witnesses as “may call live” and “may call by
`deposition” in the event that Allergan does not call any of its witnesses live at trial or attempts to
`limit the scope of cross-examination to subject matter elicited during direct examination.
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 10 of 13 PageID #: 15788
`
`
`of this list, including any changes by Plaintiff to its arguments, witness lists, or other positions.
`
`Defendants further reserve the right to call any witness live or by deposition designations for
`
`purposes of impeachment. Defendants further reserve the right to call additional witnesses live
`
`or by deposition designations (or to offer additional deposition designations from witnesses
`
`identified herein) to the extent necessary to provide foundational testimony if Plaintiff contests
`
`the authenticity or admissibility of any materials to be offered as evidence at trial. Defendants
`
`further reserve the right to substitute witnesses for the listed witnesses should any listed witness
`
`become unavailable for trial. Defendants further reserve the right to use any deposition
`
`designations identified by Defendants as either affirmative designations or as counter-
`
`designations. For all expert witnesses listed by Plaintiff, Defendants reserve the right to
`
`introduce deposition testimony in the event that such witness does not testify live at trial.
`
`Defendants further reserve the right to call any witness listed by Plaintiff on its witness list or
`
`initial disclosures (as noted below), or who otherwise appears for Plaintiff at trial.
`
`
`
`
`
`
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 11 of 13 PageID #: 15789
`
`
`
`
`
`
`Dated: July 7, 2017
`
`
` /s/ Anna G. Phillips
`Douglas H. Carsten
`Wendy Devine
`Christina E. Dashe
`Alina L. Litoshyk
`Nellie J. Amjadi
`WILSON SONSINI GOODRICH & ROSATI
`12235 El Camino Real, Suite 200
`San Diego, CA 92130-3002
`Tel: 858-350-2300
`Fax: 858-350-2399
`dcarsten@wsgr.com
`wdevine@wsgr.com
`cdashe@wsgr.com
`alitoshyk@wsgr.com
`namjadi@wsgr.com
`
`Anna G. Phillips
`Texas Bar No. 24090329
`WILSON SONSINI GOODRICH & ROSATI
`900 South Capital of Texas Highway
`Las Cimas IV, Fifth Floor
`Austin, TX 78746-5546
`Tel: 512-338-5400
`Fax: 512-338-5499
`anphillips@wsgr.com
`
`Melissa Smith
`Allen Franklin Gardner
`GILLAM & SMITH LLP
`303 S. Washington Ave.
`Marshall, Texas 75670
`Tel: 903-934-8450
`Fax: 903-934-9257
`melissa@gillamsmithlaw.com
`allen@gillamsmithlaw.com
`
`COUNSEL FOR DEFENDANTS MYLAN
`PHARMACEUTICALS INC. AND
`MYLAN INC.
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
` /s/ J.C. Rozendaal
`J.C. Rozendaal (pro hac vice)
`Michael E. Joffre (pro hac vice)
`Pauline M. Pelletier (pro hac vice)
`R. Wilson Powers III (pro hac vice)
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Ave. NW, Suite 600
`Washington, DC 20005
`Tel: 202-371-2600
`Fax: 202-371-2540
`jcrozendaal@skgf.com
`mjoffre@skgf.com
`ppelletier@skgf.com
`tpowers@skgf.com
`
`Louis B. (“Brady”) Paddock
`Texas Bar No. 00791394
`NIX, PATTERSON & ROACH L.L.P.
`2900 St. Michael Drive, Ste. 500
`Texarkana, TX 75503
`(903) 223-3999
`(903) 223-8520 (fax)
`bpaddock@nixlawfirm.com
`
`COUNSEL FOR DEFENDANT
`TEVA PHARMACEUTICALS USA, INC.
`
` /s/ Jason Craig Hamilton
`Stephen R. Smerek (pro hac vice)
`Shilpa Coorg (pro hac vice)
`Jason Craig Hamilton (pro hac vice)
`WINSTON & STRAWN LLP
`333 South Grand Avenue, 38th Floor
`Los Angeles, CA 90071-1543
`Tel: 213-615-1933
`Fax: 213-615-1750
`ssmerek@winston.com
`scoorg@winston.com
`jhamilton@winston.com
`
`Charles B. Klein (pro hac vice)
`WINSTON & STRAWN LLP
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 12 of 13 PageID #: 15790
`
`
`
`
` /s/ Azadeh Kokabi
`Michael R. Dzwonczyk
`Azadeh Kokabi
`Mark Boland
`SUGHRUE MION PLLC
`2100 Pennsylvania Ave NW, Suite 800
`Washington, DC 20037
`Tel: 202-293-7060
`Fax: 202-293-7860
`mdzwonczyk@sughrue.com
`akokabi@sughrue.com
`mboland@sughrue.com
`
`Earl Glenn Thames, Jr.
`POTTER MINTON
`110 N College Avenue, Suite 500
`Tyler, TX 75702
`Tel: 903-597-8311
`Fax: 903-593-0846
`glennthames@potterminton.com
`
`COUNSEL FOR DEFENDANT
`AKORN, INC.
`
`
`
`
`
`
`
`
`
`
`
`
`
`1700 K Street, NW
`Washington, DC 20006
`Tel: 202-282-5977
`Fax: 202-282-5100
`cklein@winston.com
`Deron R. Dacus
`Peter Aaron Kerr
`THE DACUS FIRM, PC
`821 ESE Loop 323, Suite 430
`Tyler, TX 75701
`Tel: 903-705-1117
`Fax: 903-581-2543
`ddacus@dacusfirm.com
`pkerr@dacusfirm.com
`
`COUNSEL FOR DEFENDANT
`INNOPHARMA, INC.
`
` /s/ Peter J. Curtin
`William A. Rakoczy (pro hac vice)
`Paul J. Molino (pro hac vice)
`Peter J. Curtin (pro hac vice)
`John D. Polivick (pro hac vice)
`Kevin P. Burke (pro hac vice)
`Patrick N. Abbott (pro hac vice)
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-6301
`Fax: (312) 222-6321
`wrakoczy@rmmslegal.com
`paul@rmmslegal.com
`jpolivick@rmmslegal.com
`kburke@rmmslegal.com
`pabbott@rmmslegal.com
`
`Eric H. Findlay
`Texas Bar No. 00789886
`Walter Wayne Lackey, Jr.
`Texas Bar No. 24050901
`FINDLAY CRAFT, P.C.
`102 North College Avenue, Suite900
`Tyler, TX 75702
`Tel: (903) 534-1100
`Fax: (903) 534-1137
`
`COUNSEL FOR DEFENDANT
`FAMY CARE LIMITED
`
`
`
`Case 2:15-cv-01455-WCB Document 379-2 Filed 07/25/17 Page 13 of 13 PageID #: 15791
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that a true and correct copy of the above and foregoing was served upon
`
`all counsel of record via e-mail on July 7, 2017.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ J.C. Rozendaal
`J.C. Rozendaal
`
`
`
`
`
`
`
`
`